Gold miners crushed: Time to sell your shares?

The S&P/ASX All Ords Gold (Index:^AXGD) (ASX:XGD) has sunk lower following a drop in the gold price again. Is it time to sell Newcrest Mining Limited (ASX:NCM) and its peers?

a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

So far it has been another day of declines for shareholders of Australia's gold miners. At the time of writing the S&P/ASX All Ords Gold (Index: ^AXGD) (ASX: XGD) Index has sunk 5.5% to bring its two-day decline to in excess of 10%.

Since peaking at US$1,337 an ounce during Wednesday's market sell-off, the spot gold price has now fallen by almost 6% to US$1,260 an ounce.

Some traders were betting on gold prices rising to upwards of US$2,000 an ounce if Trump won the election, unfortunately for them the opposite looks set to happen.

With many believing that Trump will end the days of low interest rates in the United States, the gold price could potentially be on the path to a level below US$1,000 an ounce now.

It comes as no surprise to see a number of Australian gold miners sink significantly lower today as a result. Here are the pick of the bunch:

Company +/-
Alacer Gold Corp – CDI (ASX: AQG) -6.3%
EVOLUTION FPO (ASX: EVN) -5.4%
Newcrest Mining Limited (ASX: NCM) -5.6%
Northern Star Resources Ltd (ASX: NST) -3%
OceanaGold Corporation (ASX: OGC) -5.8%
Perseus Mining Limited (ASX: PRU) -6.1%
Regis Resources Limited (ASX: RRL) -4.4%
Resolute Mining Limited (ASX: RSG) -6.6%
St Barbara Ltd (ASX: SBM)  -4.3%

Whilst Trump's presidency could yet throw up a few surprises in the months ahead, I feel it is inevitable that the gold price will continue its slide to US$1,000.

Although many of Australia's miners will remain hugely profitable at this level, the bumper profits that they have been making recently could come to an end and put pressure on share prices. For this reason I continue to believe that investors will be better served looking elsewhere in the market.

Motley Fool contributor James Mickleboro has no position in any stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on ⏸️ Investing

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »

⏸️ Investing

Why Fox (NASDAQ:FOX) might hurt News Corp (ASX:NWS) shareholders

News Corporation (ASX: NWS) might be facing some existential threats from its American cousins over the riots on 6 January

Read more »